Polymicrobial Biofilms in Diabetic Foot Ulcer: Pathogenic Synergy, Clinical Challenges, and Therapeutic Perspectives

Hertiani, Triana and Ummah, Kuntum Khaira and Nuryastuti, Titik (2025) Polymicrobial Biofilms in Diabetic Foot Ulcer: Pathogenic Synergy, Clinical Challenges, and Therapeutic Perspectives. Biomedical and Pharmacology Journal, 18 (4). 2536 - 2550. ISSN 09746242

[thumbnail of BPJ_Vol_18_No_4_p_2536-2550.pdf] Text
BPJ_Vol_18_No_4_p_2536-2550.pdf - Published Version
Restricted to Registered users only

Download (469kB) | Request a copy

Abstract

Diabetic foot ulcer (DFU) is a chronic complication of diabetes mellitus characterized by delayed healing and high recurrence rates. A key factor contributing to therapeutic failure is the presence of polymicrobial biofilms. Interspecies interactions within these biofilms promote EPS matrix thickening, antimicrobial resistance, immune evasion, and prolonged inflammation, thereby increasing the risk of amputation. This narrative review evaluates the clinical and therapeutic implications of these interactions and highlights strategies for effective management. A comprehensive search was conducted using Scopus, PubMed, and Google Scholar for studies published between 2015 and 2025. From 283 articles identified, 37 met the inclusion criteria and were reviewed. Results confirmed that interspecies interactions significantly impair wound healing and therapeutic outcomes in DFU. These interactions strengthen microbial persistence and delay tissue repair, underscoring the limited efficacy of conventional antimicrobial therapies. Clinically, debridement and negative pressure wound therapy (NPWT) remain the most widely supported interventions, while antibiotic antibiofilm combinations and enzymatic EPS-disrupting agents show promising synergistic effects. Emerging modalities, including phage therapy, quorum sensing inhibitors, and smart dressings, are under development but largely restricted to preclinical studies. The clinical and therapeutic impact of interspecies interactions highlights the need for multimodal DFU management. Integrating mechanical and antibiofilm approaches with future innovations such as microbiota-guided personalized therapy and adaptive wound dressings may improve healing outcomes and reduce the risk of severe complications. © 2025 Oriental Scientific Publishing Company. All rights reserved.

Item Type: Article
Additional Information: Cited by: 1; All Open Access; Gold Open Access
Uncontrolled Keywords: antibiotic agent; antiinfective agent; vancomycin; Acinetobacter baumannii; antibacterial activity; antibiotic resistance; antibiotic sensitivity; antimicrobial activity; Article; bacterial virulence; biofilm; Candida albicans; debridement; diabetes mellitus; diabetic foot; Enterococcus faecalis; Escherichia coli; foot ulcer; human; immune response; methicillin resistant Staphylococcus aureus; minimum inhibitory concentration; nonhuman; osteomyelitis; Pseudomonas aeruginosa; risk factor; Staphylococcus aureus; Staphylococcus epidermidis; systematic review; urinary tract infection
Subjects: R Medicine > RM Therapeutics. Pharmacology
R Medicine > RS Pharmacy and materia medica
Divisions: Faculty of Pharmacy
Depositing User: Muh Aly Mubarok
Date Deposited: 15 Oct 2026 06:17
Last Modified: 15 Oct 2026 06:17
URI: https://ir.lib.ugm.ac.id/id/eprint/30294

Actions (login required)

View Item
View Item